Vaxcyte's market cap is currently $10.28B. The company's EPS TTM is $-4.678; its P/E ratio is ―; Vaxcyte is scheduled to report earnings on March 3, 2025, and the estimated EPS forecast is $-1.11. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ -75.00M	$ -9.20M	$ -1.80M	$ -1.41M	$ -1.23M
Operating Income	$ -468.04M	$ -232.26M	$ -103.67M	$ -89.58M	$ -54.15M
EBITDA	$ -464.88M	$ -214.29M	$ -98.28M	$ -87.81M	$ -49.00M
Net Income	$ -402.27M	$ -239.64M	$ -100.08M	$ -87.82M	$ -53.50M
Balance Sheet
Cash & Short-Term Investments	$ 1.08B	$ 931.38M	$ 245.97M	$ 386.20M	$ 58.98M
Total Assets	$ 1.41B	$ 1.01B	$ 324.34M	$ 392.83M	$ 65.70M
Total Debt	$ 29.22M	$ 17.94M	$ 16.78M	$ 0.00	$ 161.00K
Net Debt	$ -368.23M	$ -816.72M	$ -52.20M	$ -386.20M	$ -58.81M
Total Liabilities	$ 167.45M	$ 52.56M	$ 40.32M	$ 46.98M	$ 172.07M
Stockholders' Equity	$ 1.24B	$ 953.61M	$ 284.02M	$ 345.84M	$ -106.37M
Cash Flow
Free Cash Flow	$ -364.67M	$ -176.44M	$ -127.95M	$ -47.78M	$ -48.34M
Operating Cash Flow	$ -296.79M	$ -170.60M	$ -121.39M	$ -46.63M	$ -47.15M
Investing Cash Flow	$ -773.31M	$ 74.58M	$ -212.31M	$ -1.10M	$ -1.20M
Financing Cash Flow	$ 639.81M	$ 861.55M	$ 17.80M	$ 374.87M	$ 41.57M

Currency in USD

Vaxcyte Earnings and Revenue History

Income Statement >

Vaxcyte Debt to Assets

Balance Sheet >

Vaxcyte Cash Flow

Cash Flow >

Vaxcyte Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing